- Home
- ACIU vs IPI Comparison
ACIU vs IPI Comparison
Compare ACIU & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- IPI
- Stock Information
- Founded
- ACIU 2003
- IPI 2000
- Country
- ACIU Switzerland
- IPI United States
- Employees
- ACIU N/A
- IPI N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- ACIU Health Care
- IPI Industrials
- Exchange
- ACIU Nasdaq
- IPI Nasdaq
- Market Cap
- ACIU 189.1M
- IPI 475.8M
- IPO Year
- ACIU 2016
- IPI 2008
- Fundamental
- Price
- ACIU $2.03
- IPI $33.95
- Analyst Decision
- ACIU Strong Buy
- IPI Strong Sell
- Analyst Count
- ACIU 1
- IPI 1
- Target Price
- ACIU $12.00
- IPI $19.00
- AVG Volume (30 Days)
- ACIU 120.2K
- IPI 145.7K
- Earning Date
- ACIU 08-05-2025
- IPI 08-04-2025
- Dividend Yield
- ACIU N/A
- IPI N/A
- EPS Growth
- ACIU N/A
- IPI N/A
- EPS
- ACIU N/A
- IPI N/A
- Revenue
- ACIU $32,014,254.00
- IPI $217,865,000.00
- Revenue This Year
- ACIU N/A
- IPI $11.06
- Revenue Next Year
- ACIU $533.21
- IPI N/A
- P/E Ratio
- ACIU N/A
- IPI N/A
- Revenue Growth
- ACIU 91.20
- IPI N/A
- 52 Week Low
- ACIU $1.43
- IPI $20.75
- 52 Week High
- ACIU $4.26
- IPI $39.01
- Technical
- Relative Strength Index (RSI)
- ACIU 56.32
- IPI 41.61
- Support Level
- ACIU $2.03
- IPI $34.36
- Resistance Level
- ACIU $2.15
- IPI $37.84
- Average True Range (ATR)
- ACIU 0.14
- IPI 1.09
- MACD
- ACIU -0.00
- IPI -0.18
- Stochastic Oscillator
- ACIU 79.28
- IPI 17.58
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About IPI Intrepid Potash Inc
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.